Beauty Right Introduces "Dietary Nutritional Supplement" with GLP-1 Active Peptide Capsules
22 avr. 2024 08h00 HE
|
Beauty Right
New York, April 22, 2024 (GLOBE NEWSWIRE) -- Beauty Right, a brand specializing in dietary supplements, introduces GLP-1 Active Peptide Capsules, a nutritional supplement designed to help people...
Wholesale Weight Loss: Sesame Unveils Specialized Care for Weight Loss with Pricing Exclusively for Costco Members
02 avr. 2024 10h59 HE
|
Sesame
NEW YORK CITY, April 02, 2024 (GLOBE NEWSWIRE) -- Sesame, the company building a radically new healthcare system for uninsured Americans and those with high-deductible plans, today unveiled an...
Noom Strengthens Commercial Leadership Team with Trio of Executive Healthcare Appointments
07 mars 2024 08h03 HE
|
Noom Inc
Jodi Bryant joins as President, Healthcare, Matt Moran as Chief Strategy Officer, and Cody Fair elevated to Chief Commercial Officer at Noom.
Noom Earns Highest CDC Recognition for Diabetes Prevention Program
05 mars 2024 08h47 HE
|
Noom Inc
The CDC Full Plus Recognition sets a new standard for digital health solutions providing metabolic health, chronic disease prevention, and weight loss.
NATIONALLY RANKED ROSEN LAW FIRM Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation – ALT
19 févr. 2024 16h53 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 19, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Altimmune,...
Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist for Additional Reduction of Obesity - Associated Inflammation
05 janv. 2024 07h00 HE
|
Tiziana Life Sciences Ltd.
Tiziana Life Sciences Files New Patent Application for Combination Therapy of anti-CD3 (Foralumab) with GLP-1 Receptor Agonist
Zealand Pharma to highlight obesity pipeline at R&D Event on December 5
04 déc. 2023 02h30 HE
|
Zealand Pharma
Press release – No. 16 / 2023 Zealand Pharma to highlight obesity pipeline at R&D Event on December 5 Event to be hosted by company management and feature key external scientific and...
Evoke Pharma & EVERSANA Unveil Cost Savings Real-World Data Demonstrating Meaningfully Reduced Healthcare Costs for Patients Using GIMOTI Over Oral Metoclopramide Presented at the American College of Gastroenterology 2023
31 oct. 2023 08h30 HE
|
Evoke Pharma, Inc.
SOLANA BEACH, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
Workplace Weight Loss & Wellness Program Unveiled
04 oct. 2023 13h27 HE
|
Telegenixx
Telegenix's New Program Enables Employers to Provide Access to Pharma-Assisted Weight Loss at a Cost of $299 per Month, 70% Below the Industry Average
Structure Therapeutics Announces $300 Million Private Placement Equity Financing
29 sept. 2023 07h32 HE
|
Structure Therapeutics Inc.
$300 million financing includes significant participation from a number of large healthcare dedicated institutional and mutual fund investors Net proceeds, along with existing cash, cash equivalents...